145.71
Icon Plc 주식(ICLR)의 최신 뉴스
Analysts Estimate Icon PLC (ICLR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report - Business Wire
ICON Dominates Phase 1 Clinical Trials: Outperforms All Major CROs in 17 Key Metrics - Stock Titan
Do You Believe in the Upside Potential of ICON PLC (ICLR)? - Insider Monkey
Clinical Trial Investigative Site Network Market Top Players - openPR.com
Launch Your Career as a Life Science Intern at ICON, Apply Now! - BioTecNika
Icon (ICLR) Gets a Buy from Leerink Partners - The Globe and Mail
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $187 - 富途牛牛
ICON plc stock price target lowered to $187 at Truist Securities - Investing.com Nigeria
ICON plc stock price target lowered to $187 at Truist Securities By Investing.com - Investing.com South Africa
WCM Investment Management, LLC Significantly Reduces Stake in Icon PLC - GuruFocus
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability - 01net
ICON and Its Employees Recognised as Clinical Research Industry - GuruFocus
Should You Hold ICON PLC (ICLR)? - MSN
Will ICON PLC (ICLR) Benefit from R&D Spending? - Insider Monkey
Barclays Sticks to Their Hold Rating for Icon (ICLR) - The Globe and Mail
ICON plc Schedules Q2 2025 Earnings Call - TipRanks
ICON Announces Q2 2025 Earnings Call - AInvest
ICON plc Reports Strong Interim Financial Results for Early 2025 - TipRanks
Robert W. Baird Maintains Hold Rating for Icon (ICLR) with $150 Price Target - AInvest
Medical Device Regulatory Affairs Market Top PlayersICON, - openPR.com
ICON plc Announces 2025 AGM and Key Resolutions - TipRanks
Icon PLC (ICLR) Shares Up 3.47% on Jun 6 - GuruFocus
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.
ICON Public Limited (NASDAQ:ICLR) Short Interest Up 25.4% in May - Defense World
Icon PLC (ICLR) Stock Price Up 4.49% on Jun 4 - GuruFocus
ICON at William Blair Conference: Strategic Focus Amid Challenges - Investing.com
ICON Becomes the First Large Clinical Research Organization to Fully Integrate Medidata Clinical Data Studio, Streamlining Data Management and Review - mx.advfn.com
Here's Why You Should Retain ICLR Stock in Your Portfolio Now - TradingView
Icon PLC (ICLR) Down 9.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
ICON plc to Present at the William Blair 45th Annual Growth Stoc - GuruFocus
ICON plc to Present at Annual Growth Stock Conference By Investing.com - Investing.com South Africa
ICLR December 2026 Options Begin Trading - Nasdaq
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference - BioSpace
ICON plc to Present at Annual Growth Stock Conference - Investing.com
ICON plc to Present at William Blair Growth Stock Conference - TipRanks
ICON’s SWOT analysis: cro stock faces headwinds amid potential rebound - Investing.com
ICON Life Science Internship For BSc & MSc – Applications Closing Soon! Hurry! - BioTecNika
Redburn Atlantic Adjusts Icon (ICLR) Price Target Amid Market Uncertainty | ICLR Stock News - GuruFocus
ICON Plc stock hits 52-week low at $127.51 amid market challenges By Investing.com - Investing.com South Africa
ICON Plc stock hits 52-week low at $127.51 amid market challenges - Investing.com Nigeria
ICON releases its ICON Cares 2024 Report | ICLR Stock News - GuruFocus
ICON releases its ICON Cares 2024 Report - Silicon Canals
ICON Releases ICON Cares 2024 Report Highlighting ESG Achievements - TipRanks
ICON Leads CRO Industry in Sustainability: Achieves 70% GHG Reduction and TIME Recognition - Stock Titan
ICON holds lead as most active CRO, GlobalData finds - The Pharma Letter
Icon (ICLR) Maintains Outperform Rating Amid Price Target Adjustment | ICLR Stock News - GuruFocus
Icon (ICLR) Price Target Reduced by Mizuho to $173 | ICLR Stock News - GuruFocus
자본화:
|
볼륨(24시간):